Viridian Therapeutic (VRDN) PT Raised to $45 at RBC Capital Nov 6, 2025 04:26AM
RBC on Viridian (VRDN): 'Compelling THRIVE-2 Data Could Change the Game for Chronic TED & VRDN'; PT Raised Dec 17, 2024 09:16AM
Viridian Therapeutic (VRDN) PT Raised to $44 at RBC Capital Sep 13, 2024 06:33AM
Viridian Therapeutics (VRDN) Prices Upsized 10.67M Share Offering at $18.75/sh Sep 12, 2024 06:12AM
Viridian Therapeutics Announces Pricing of Upsized Public Offering of Shares of Common Stock and Preferred Stock Sep 11, 2024 11:25PM


Sep 10, 2024 04:01PM Viridian Therapeutics (VRDN) Announces Proposed $150M Share and Warrant Offering
Sep 10, 2024 04:01PM Viridian Therapeutics Announces Proposed Underwritten Public Offering of Common Stock and Preferred Stock
Jun 11, 2024 12:47PM RBC Capital Reiterates Outperform Rating on Viridian Therapeutic (VRDN)